Identification of potential histone deacetylase1 (HDAC1) inhibitors using multistep virtual screening approach including SVM model, pharmacophore modeling, molecular docking and biological evaluation

References

• Abel, R., Young, T., Farid, R., Berne, B. J., & Friesner, R. A. (2008). Role of the active-site solvent in the thermodynamics of factor Xa ligand binding. Journal of the American Chemical Society, 130(9), 2817–2831. doi: 10.1021/ja0771033
   PubMed Web of Science ®Google Scholar
• Biovia, D. (2017). Discovery studio modeling environment, (Version 4).
   Google Scholar
• Brodney, M. A., Barreiro, G., Ogilvie, K., Hajos-Korcsok, E., Murray, J., Vajdos, F., … O’Neill, B. T. (2012). Spirocyclic sulfamides as beta-secretase 1 (BACE-1) inhibitors for the treatment of Alzheimer's disease: Utilization of structure based drug design, WaterMap, and CNS penetration studies to identify centrally efficacious inhibitors. Journal of Medicinal Chemistry, 55(21), 9224–9239. doi: 10.1021/jm3009426
   PubMed Web of Science ®Google Scholar
• Cai, J., Wei, H., Hong, K. H., Wu, X., Cao, M., Zong, X., … Ji, M. (2015). Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors. European Journal of Medicinal Chemistry, 96, 1–13. doi: 10.1016/j.ejmech.2015.04.002
   PubMed Web of Science ®Google Scholar
• Chandra, S., Pandey, J., Tamrakar, A. K., & Siddiqi, M. I. (2017). Multiple machine learning based descriptive and predictive workflow for the identification of potential PTP1B inhibitors. Journal of Molecular Graphics and Modelling, 71, 242–256. doi: 10.1016/j.jmgm.2016.10.020
   PubMed Web of Science ®Google Scholar
• Chih-Chung Chang, C.-J. L. (2011). LIBSVM: A library for support vector machines. ACM Transactions on Intelligent Systems and Technology (Technology), 2(3), 27. doi: 10.1145/1961189.1961199
   Web of Science ®Google Scholar
• CHEMBL. https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL325.
   Google Scholar
• Chemical Computing Group ULC. (2013). Molecular operating environment (Version 2013.08).
   Google Scholar
• Chen, K., Xu, L., & Wiest, O. (2013). Computational exploration of zinc binding groups for HDAC inhibition. The Journal of Organic Chemistry, 78(10), 5051–5055. doi: 10.1021/jo400406g
   PubMed Web of Science ®Google Scholar
• Choi, J. H., Kwon, H. J., Yoon, B. I., Kim, J. H., Han, S. U., Joo, H. J., & Kim, D. Y. (2001). Expression profile of histone deacetylase 1 in gastric cancer tissues. Japanese Journal of Cancer Research, 92(12), 1300–1304. doi: 10.1111/j.1349-7006.2001.tb02153.x
   PubMedGoogle Scholar
• D.E.ShawResearch. (2016). Desmond molecular dynamics system.
   Google Scholar
• Di Pompo, G., Salerno, M., Rotili, D., Valente, S., Zwergel, C., Avnet, S., … Mai, A. (2015). Novel histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in sarcoma cancer stem cells. Journal of Medicinal Chemistry, 58(9), 4073–4079. doi: 10.1021/acs.jmedchem.5b00126
   PubMed Web of Science ®Google Scholar
• Fang, J., Pang, X., Yan, R., Lian, W., Li, C., Wang, Q., … Du, G. H. (2016). Discovery of neuroprotective compounds by machine learning approaches. RSC Advances, 6(12), 15. doi: 10.1039/C5RA23035G
   Web of Science ®Google Scholar
• Fang, J., Yang, R., Gao, L., Zhou, D., Yang, S., Liu, A. L., & Du, G. H. (2013). Predictions of BuChE inhibitors using support vector machine and naive Bayesian classification techniques in drug discovery. Journal of Chemical Information and Modeling, 53(11), 3009–3020. doi: 10.1021/ci400331p
   PubMed Web of Science ®Google Scholar
• Franke, L., Byvatov, E., Werz, O., Steinhilber, D., Schneider, P., & Schneider, G. (2005). Extraction and visualization of potential pharmacophore points using support vector machines: Application to ligand-based virtual screening for COX-2 inhibitors. Journal of Medicinal Chemistry, 48(22), 6997–7004. doi: 10.1021/jm050619h
   PubMed Web of Science ®Google Scholar
• Fukui, Y., Narita, K., Dan, S., Yamori, T., Ito, A., Yoshida, M., & Katoh, T. (2014). Total synthesis of burkholdacs A and B and 5,6,20-tri-epi-burkholdac A: HDAC inhibition and antiproliferative activity. European Journal of Medicinal Chemistry, 76, 301–313. doi: 10.1016/j.ejmech.2014.02.044
   PubMed Web of Science ®Google Scholar
• Giannini, G., Vesci, L., Battistuzzi, G., Vignola, D., Milazzo, F. M., Guglielmi, M. B., … Cabri, W. (2014). ST7612AA1, a thioacetate-omega(gamma-lactam carboxamide) derivative selected from a novel generation of oral HDAC inhibitors. Journal of Medicinal Chemistry, 57(20), 8358–8377. doi: 10.1021/jm5008209
   PubMed Web of Science ®Google Scholar
• Glozak, M. A., Sengupta, N., Zhang, X., & Seto, E. (2005). Acetylation and deacetylation of non-histone proteins. Gene, 363, 15–23. doi: 10.1016/j.gene.2005.09.010
   PubMed Web of Science ®Google Scholar
• Halkidou, K., Gaughan, L., Cook, S., Leung, H. Y., Neal, D. E., & Robson, C. N. (2004). Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer. The Prostate, 59(2), 177–189. doi: 10.1002/pros.20022
   PubMed Web of Science ®Google Scholar
• He, S., Dong, G., Wang, Z., Chen, W., Huang, Y., Li, Z., … Sheng, C. (2015). Discovery of Novel Multiacting topoisomerase I/II and histone deacetylase inhibitors. ACS Medicinal Chemistry Letters, 6(3), 239–243. doi: 10.1021/ml500327q
   PubMed Web of Science ®Google Scholar
• Heikamp, K., & Bajorath, J. (2013). Comparison of confirmed inactive and randomly selected compounds as negative training examples in support vector machine-based virtual screening. Journal of Chemical Information and Modeling, 53(7), 1595–1601. doi: 10.1021/ci4002712
   PubMed Web of Science ®Google Scholar
• Hou, X., Du, J., Liu, R., Zhou, Y., Li, M., Xu, W., & Fang, H. (2015). Enhancing the sensitivity of pharmacophore-based virtual screening by incorporating customized ZBG features: A case study using histone deacetylase 8. Journal of Chemical Information and Modeling, 55(4), 861–871. doi: 10.1021/ci500762z
   PubMed Web of Science ®Google Scholar
• Hsu, C.-W., Shou, D., Huang, R., Khuc, T., Dai, S., Zheng, W., … Xia, M. (2016). Identification of HDAC inhibitors using a cell-based HDAC I/II assay. Journal of Biomolecular Screening, 21(6), 643–652. doi: 10.1177/1087057116629381
   PubMedGoogle Scholar
• Ibrahim Uba, A., & Yelekci, K. (2019). Homology modeling of human histone deacetylase 10 and design of potential selective inhibitors. Journal of Biomolecular Structure and Dynamics, 37(14), 3627–3636. doi: 10.1080/07391102.2018.1521747
   PubMed Web of Science ®Google Scholar
• Inche, A. G., & La Thangue, N. B. (2006). Chromatin control and cancer-drug discovery: Realizing the promise. Drug Discovery Today, 11(3-4), 97–109. doi: 10.1016/S1359-6446(05)03691-3
   PubMed Web of Science ®Google Scholar
• Jurman, G., Riccadonna, S., & Furlanello, C. (2012). A comparison of MCC and CEN error measures in multi-class prediction. PLoS One, 7(8), e41882. doi: 10.1371/journal.pone.0041882
   PubMed Web of Science ®Google Scholar
• Kashyap, K., & Kakkar, R. (2019). An insight into selective and potent inhibition of histone deacetylase 8 through induced-fit docking, pharmacophore modeling and QSAR studies. Journal of Biomolecular Structure and Dynamics, 1–18. doi: 10.1080/07391102.2019.1567388
   PubMed Web of Science ®Google Scholar
• Krishna, S., Shukla, S., Lakra, A. D., Meeran, S. M., & Siddiqi, M. I. (2017). Identification of potent inhibitors of DNA methyltransferase 1 (DNMT1) through a pharmacophore-based virtual screening approach. Journal of Molecular Graphics and Modelling, 75, 174–188. doi: 10.1016/j.jmgm.2017.05.014
   PubMed Web of Science ®Google Scholar
• Kurczab, R., Smusz, S., & Bojarski, A. J. (2014). The influence of negative training set size on machine learning-based virtual screening. Journal of Cheminformatics, 6(1), 32. doi: 10.1186/1758-2946-6-32
   PubMedGoogle Scholar
• Lauffer, B. E. L., Mintzer, R., Fong, R., Mukund, S., Tam, C., Zilberleyb, I., … Steiner, P. (2013). Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viability. Journal of Biological Chemistry, 288(37), 26926–26943. doi: 10.1074/jbc.M113.490706
   PubMed Web of Science ®Google Scholar
• Lepp, Z., Kinoshita, T., & Chuman, H. (2006). Screening for new antidepressant leads of multiple activities by support vector machines. Journal of Chemical Information and Modeling, 46(1), 158–167. doi: 10.1021/ci050301y
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46(1-3), 3–26. doi: 10.1016/S0169-409X(96)00423-1
   PubMed Web of Science ®Google Scholar
• Li, X., Hou, J., Li, X., Jiang, Y., Liu, X., Mu, W., … Xu, W. (2015). Development of 3-hydroxycinnamamide-based HDAC inhibitors with potent in vitro and in vivo anti-tumor activity. European Journal of Medicinal Chemistry, 89, 628–637. doi: 10.1016/j.ejmech.2014.10.077
   PubMed Web of Science ®Google Scholar
• Li, X., Inks, E. S., Li, X., Hou, J., Chou, C. J., Zhang, J., … Xu, W. (2014). Discovery of the first N-hydroxycinnamamide-based histone deacetylase 1/3 dual inhibitors with potent oral antitumor activity. Journal of Medicinal Chemistry, 57(8), 3324–3341. doi: 10.1021/jm401877m
   PubMed Web of Science ®Google Scholar
• Li, Y., Wang, L., Liu, Z., Li, C., Xu, J., Gu, Q., & Xu, J. (2015). Predicting selective liver X receptor β agonists using multiple machine learning methods. Molecular Biosystems, 11(5), 1241. doi: 10.1039/C4MB00718B
   PubMedGoogle Scholar
• Li, Y., Wang, Y., Xie, N., Xu, M., Qian, P., Zhao, Y., & Li, S. (2015). Design, synthesis and antiproliferative activities of novel benzamides derivatives as HDAC inhibitors. European Journal of Medicinal Chemistry, 100, 270–276. doi: 10.1016/j.ejmech.2015.05.045
   PubMed Web of Science ®Google Scholar
• Liu, X. H., Ma, X. H., Tan, C. Y., Jiang, Y. Y., Go, M. L., Low, B. C., & Chen, Y. Z. (2009). Virtual screening of Abl inhibitors from large compound libraries by support vector machines. Journal of Chemical Information and Modeling, 49(9), 2101–2110. doi: 10.1021/ci900135u
   PubMed Web of Science ®Google Scholar
• Liu, X. H., Song, H. Y., Zhang, J. X., Han, B. C., Wei, X. N., Ma, X. H., … Chen, Y. Z. (2010). Identifying novel type ZBGs and nonhydroxamate HDAC inhibitors through a SVM based virtual screening approach. Molecular Informatics, 29(5), 407–420. doi: 10.1002/minf.200900014
   PubMed Web of Science ®Google Scholar
• Liu, Y.-M., Lee, H.-Y., Chen, C.-H., Lee, C.-H., Wang, L.-T., Pan, S.-L., … Liou, J.-P. (2015). 1-Arylsulfonyl-5-(N-hydroxyacrylamide)tetrahydroquinolines as potent histone deacetylase inhibitors suppressing the growth of prostate cancer cells. European Journal of Medicinal Chemistry, 89, 320–330. doi: 10.1016/j.ejmech.2014.10.052
   PubMed Web of Science ®Google Scholar
• Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000). Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature, 408(6810), 377–381. doi: 10.1038/35042612
   PubMed Web of Science ®Google Scholar
• Ma, X. H., Wang, R., Tan, C. Y., Jiang, Y. Y., Lu, T., Rao, H. B., … Chen, Y. Z. (2010). Virtual screening of selective multitarget kinase inhibitors by combinatorial support vector machines. Molecular Pharmaceutics, 7(5), 1545–1560. doi: 10.1021/mp100179t
   PubMed Web of Science ®Google Scholar
• Marks, P., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001). Histone deacetylases and cancer: Causes and therapies. Nature Reviews Cancer, 1(3), 194–202. doi: 10.1038/35106079
   PubMed Web of Science ®Google Scholar
• maybridge. Maybridge database. Retrieved from http://www.maybridge.com/
   Google Scholar
• Melagraki, G., Afantitis, A., Sarimveis, H., Koutentis, P. A., Kollias, G., & Igglessi-Markopoulou, O. (2009). Predictive QSAR workflow for the in silico identification and screening of novel HDAC inhibitors. Molecular Diversity, 13(3), 301–311. doi: 10.1007/s11030-009-9115-2
   PubMed Web of Science ®Google Scholar
• Micelli, C., & Rastelli, G. (2015). Histone deacetylases: Structural determinants of inhibitor selectivity. Drug Discovery Today, 20(6), 718–735. doi: 10.1016/j.drudis.2015.01.007
   PubMed Web of Science ®Google Scholar
• Millard, C. J., Watson, P. J., Celardo, I., Gordiyenko, Y., Cowley, S. M., Robinson, C. V., … Schwabe, J. W. R. (2013). Class I HDACs share a common mechanism of regulation by inositol phosphates. Molecular Cell, 51(1), 57–67. doi: 10.1016/j.molcel.2013.05.020
   PubMed Web of Science ®Google Scholar
• Miyake, K., Yoshizumi, T., Imura, S., Sugimoto, K., Batmunkh, E., Kanemura, H., … Shimada, M. (2008). Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: Correlation with poor prognosis with possible regulation. Pancreas, 36(3), e1–9. doi: 10.1097/MPA.0b013e31815f2c2a
   PubMed Web of Science ®Google Scholar
• Mysinger, M. M., Carchia, M., Irwin, J. J., & Shoichet, B. K. (2012). Directory of useful decoys, enhanced (DUD-E): Better ligands and decoys for better benchmarking. Journal of Medicinal Chemistry, 55(14), 6582–6594. doi: 10.1021/jm300687e
   PubMed Web of Science ®Google Scholar
• Ni, M., Esposito, E., Raj, V. P., Muzi, L., Zunino, F., Zuco, V., … Dal Pozzo, A. (2015). New macrocyclic analogs of the natural histone deacetylase inhibitor FK228; design, synthesis and preliminary biological evaluation. Bioorganic & Medicinal Chemistry, 23(21), 6785–6793. doi: 10.1016/j.bmc.2015.10.004
   PubMed Web of Science ®Google Scholar
• Pan, L. N., Lu, J., & Huang, B. (2007). HDAC inhibitors: A potential new category of anti-tumor agents. Cellular & Molecular Immunology, 4(5), 337–343.
   PubMed Web of Science ®Google Scholar
• Park, H., Kim, S., Kim, Y. E., & Lim, S. J. (2010). A structure-based virtual screening approach toward the discovery of histone deacetylase inhibitors: Identification of promising zinc-chelating groups. ChemMedChem, 5(4), 591–597. doi: 10.1002/cmdc.200900500
   PubMed Web of Science ®Google Scholar
• Peng, F.-W., Xuan, J., Wu, T.-T., Xue, J.-Y., Ren, Z.-W., Liu, D.-K., … Shi, L. (2016). Design, synthesis and biological evaluation of N-phenylquinazolin-4-amine hybrids as dual inhibitors of VEGFR-2 and HDAC. European Journal of Medicinal Chemistry, 109, 1–12. doi: 10.1016/j.ejmech.2015.12.033
   PubMed Web of Science ®Google Scholar
• Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., Ferrin, T. E. (2004). UCSF Chimera--a visualization system for exploratory research and analysis. Journal of computational chemistry, 25(13), 1605–12. doi: 10.1002/jcc.20084
   Google Scholar
• Ranjan, R., Ahamad, N., & Ahmed, S. (2014). Fission yeast Drp1 is an essential protein required for recovery from DNA damage and chromosome segregation. DNA Repair (Repair), 24, 98–106. doi: 10.1016/j.dnarep.2014.09.006
   PubMed Web of Science ®Google Scholar
• Ropero, S., & Esteller, M. (2007). The role of histone deacetylases (HDACs) in human cancer. Molecular Oncology, 1(1), 19–25. doi: 10.1016/j.molonc.2007.01.001
   PubMed Web of Science ®Google Scholar
• Salvador, L. A., Park, H., Al-Awadhi, F. H., Liu, Y., Kim, B., Zeller, S. L., … Luesch, H. (2014). Modulation of activity profiles for largazole-based HDAC inhibitors through alteration of prodrug properties. ACS Medicinal Chemistry Letters, 5(8), 905–910. doi: 10.1021/ml500170r
   PubMed Web of Science ®Google Scholar
• Santos-Martins, D., Forli, S., Ramos, M. J., & Olson, A. J. (2014). AutoDock4(Zn): An improved AutoDock force field for small-molecule docking to zinc metalloproteins. Journal of Chemical Information and Modeling, 54(8), 2371–2379. doi: 10.1021/ci500209e
   PubMed Web of Science ®Google Scholar
• Schrödinger. (2016). Maestro (Version 2016.1). NewYork, USA.
   Google Scholar
• Schrödinger. (2019). Release 2018-2: QikProp, Schrödinger, LLC, New York, NY.
   Google Scholar
• Schrödinger (2017). WaterMap (Version 2017.1). NewYork, USA.
   Google Scholar
• Sixto-Lopez, Y., Bello, M., & Correa-Basurto, J. (2019). Insights into structural features of HDAC1 and its selectivity inhibition elucidated by Molecular dynamic simulation and Molecular Docking. Journal of Biomolecular Structure and Dynamics, 37(3), 584–610. doi: 10.1080/07391102.2018.1441072
   PubMed Web of Science ®Google Scholar
• Sixto-Lopez, Y., Bello, M., & Correa-Basurto, J. (2018). Structural and energetic basis for the inhibitory selectivity of both catalytic domains of dimeric HDAC6. Journal of Biomolecular Structure and Dynamics, 1–20. doi: 10.1080/07391102.2018.1557560
   PubMed Web of Science ®Google Scholar
• Sodji, Q. H., Kornacki, J. R., McDonald, J. F., Mrksich, M., & Oyelere, A. K. (2015). Design and structure activity relationship of tumor-homing histone deacetylase inhibitors conjugated to folic and pteroic acids. European Journal of Medicinal Chemistry, 96, 340–359. doi: 10.1016/j.ejmech.2015.04.014
   PubMed Web of Science ®Google Scholar
• Taddei, A., Maison, C., Roche, D., & Almouzni, G. (2001). Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases. Nature Cell Biology, 3(2), 114–120. doi: 10.1038/35055010
   PubMed Web of Science ®Google Scholar
• Tang, C., Li, C., Zhang, S., Hu, Z., Wu, J., Dong, C., … Zhou, H.-B. (2015). Novel bioactive hybrid compound dual targeting estrogen receptor and histone deacetylase for the treatment of breast cancer. Journal of Medicinal Chemistry, 58(11), 4550–4572. doi: 10.1021/acs.jmedchem.5b00099
   PubMed Web of Science ®Google Scholar
• Tang, H., Wang, X. S., Huang, X.-P., Roth, B. L., Butler, K. V., Kozikowski, A. P., … Tropsha, A. (2009). Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation. Journal of Chemical Information and Modeling, 49(2), 461–476. doi: 10.1021/ci800366f
   PubMed Web of Science ®Google Scholar
• Thangaraju, M., Carswell, K. N., Prasad, P. D., & Ganapathy, V. (2009). Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3. Biochemical Journal, 417(1), 379–389. doi: 10.1042/BJ20081132
   PubMedGoogle Scholar
• Uba, A. I., & Yelekci, K. (2018). Identification of potential isoform-selective histone deacetylase inhibitors for cancer therapy: A combined approach of structure-based virtual screening, ADMET prediction and molecular dynamics simulation assay. Journal of Biomolecular Structure and Dynamics, 36(12), 3231–3245. doi: 10.1080/07391102.2017.1384402
   PubMed Web of Science ®Google Scholar
• Vadivelan, S., Sinha, B. N., Rambabu, G., Boppana, K., & Jagarlapudi, S. A. (2008). Pharmacophore modeling and virtual screening studies to design some potential histone deacetylase inhibitors as new leads. Journal of Molecular Graphics and Modelling, 26(6), 935–946. doi: 10.1016/j.jmgm.2007.07.002
   PubMed Web of Science ®Google Scholar
• Vihinen, M. (2012). How to evaluate performance of prediction methods? Measures and their interpretation in variation effect analysis. BMC Genomics, 13(Suppl 4), S2. doi: 10.1186/1471-2164-13-S4-S2
   PubMedGoogle Scholar
• Wang, Y., Yang, L., Hou, J., Zou, Q., Gao, Q., Yao, W., … Zhang, J. (2019). Hierarchical virtual screening of the dual MMP-2/HDAC-6 inhibitors from natural products based on pharmacophore models and molecular docking. Journal of Biomolecular Structure and Dynamics, 37(3), 649–670. doi: 10.1080/07391102.2018.1434833
   PubMed Web of Science ®Google Scholar
• Wen, J., Bao, Y., Niu, Q., Yang, J., Fan, Y., Li, J., … Liu, D. (2016). Identification of N-(6-mercaptohexyl)-3-(4-pyridyl)-1H-pyrazole-5-carboxamide and its disulfide prodrug as potent histone deacetylase inhibitors with in vitro and in vivo anti-tumor efficacy. European Journal of Medicinal Chemistry, 109, 350–359. doi: 10.1016/j.ejmech.2016.01.013
   PubMed Web of Science ®Google Scholar
• Wu, R., Lu, Z., Cao, Z., & Zhang, Y. (2011). Zinc chelation with hydroxamate in histone deacetylases modulated by water access to the linker binding channel. Journal of the American Chemical Society, 133(16), 6110–6113. doi: 10.1021/ja111104p
   PubMed Web of Science ®Google Scholar
• Yang, F., Baumann, C., Viveiros, M. M., & De La Fuente, R. (2012). Histone hyperacetylation during meiosis interferes with large-scale chromatin remodeling, axial chromatid condensation and sister chromatid separation in the mammalian oocyte. The International Journal of Developmental Biology, 56(10-11-12), 889–899. doi: 10.1387/ijdb.120246rd
   PubMed Web of Science ®Google Scholar
• Yang, F., Zhang, T., Wu, H., Yang, Y., Liu, N., Chen, A., … Chen, Y. (2014). Design and optimization of novel hydroxamate-based histone deacetylase inhibitors of Bis-substituted aromatic amides bearing potent activities against tumor growth and metastasis. Journal of Medicinal Chemistry, 57(22), 9357–9369. doi: 10.1021/jm5012148
   PubMed Web of Science ®Google Scholar
• Yap, C. W. (2011). PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints. Journal of Computational Chemistry, 32(7), 1466–1474. doi: 10.1002/jcc.21707
   PubMed Web of Science ®Google Scholar
• Yao, Y., Tu, Z., Liao, C., Wang, Z., Li, S., Yao, H., … Jiang, S. (2015). Discovery of novel class i histone deacetylase inhibitors with promising in vitro and in vivo antitumor activities. Journal of Medicinal Chemistry, 58(19), 7672–7680. doi: 10.1021/acs.jmedchem.5b01044
   PubMed Web of Science ®Google Scholar
• Zhang, X., Kong, Y., Zhang, J., Su, M., Zhou, Y., Zang, Y., … Lu, W. (2015). Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors. European Journal of Medicinal Chemistry, 95, 127–135. doi: 10.1016/j.ejmech.2015.03.035
   PubMed Web of Science ®Google Scholar
• Zhang, L., Minyong, L., Feng, J., Fang, H., & Xu, W. (2012). Discovery of a novel histone deacetylase 8 inhibitor by virtual screening. Medicinal Chemistry Research, 12(2), 5. doi: 10.1007/s00044-010-9519-7
   Google Scholar
• Zhang, Z., Yamashita, H., Toyama, T., Sugiura, H., Ando, Y., Mita, K., … Iwase, H. (2005). Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast*. Breast Cancer Research and Treatment, 94(1), 11–16. doi: 10.1007/s10549-005-6001-1
   PubMed Web of Science ®Google Scholar